ArticleMethods in molecular biology (Clifton, N.J.)2026
Deep Protease Profiling to Define the Substrate Specificity of ADAMTS Proteases.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- PhageScout: Protease Cleavage Site Prediction Using an Experimental Substrate Phage Display Motif-Based Approach.International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Determining the active site specificity of proteases is critically important for defining their role in biological systems. This article outlines a method for coupling substrate phage display with high-throughput sequencing to comprehensively define the active site specificity of proteases. We call this method deep protease profiling. We apply deep protease profiling to the metalloprotease ADAMTS13, a member of the metzincin family of proteases, that helps maintain the integrity of the cardiovascular system. The only known substrate for ADAMTS13 is von Willebrand factor (VWF), a multimeric glycoprotein that recruits platelets and other immune cells to sites of vascular injury. However, our understanding of ADAMTS13 substrate specificity remains limited. Deep protease profiling of ADAMTS13 initially revealed very few significantly cleaved peptides. However, substituting the phage display library into the P3-P3' interval of VWF73, a minimal VWF substrate used to detect ADAMTS13 activity, revealed over 1600 cleaved peptides. These peptides aligned into a clear substrate recognition motif, confirming the importance of exosite engagement and providing a detailed recognition profile that may guide the identification of novel biological substrates for ADAMTS13. This method is broadly applicable to other members of the ADAMTS protease family, whose substrate specificity remains poorly characterized.
Indexed as
Identifiers
41917361What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.